Life in the RAS Lane: Frank McCormick and the Pursuit of Pancreatic Cancer’s Driver
Frank McCormick, PhD, FAACR, reflected on a career chasing the notorious RAS oncogene that earned him the inaugural Stephenson...
Frank McCormick, PhD, FAACR, reflected on a career chasing the notorious RAS oncogene that earned him the inaugural Stephenson...
Researchers highlighted AI's potential to enhance cancer research, including to discover cancer drivers and new therapeutic opportunities.
New advances in our understanding of cancer cachexia may provide hope for patients with pancreatic cancer.
Susan Kaech and Ton Schumacher gave thought-provoking keynotes at the AACR Special Conference in Cancer Research: Tumor Immunology and...
The AACR Special Conference: Liquid Biopsy features experts exploring all facets of this exciting technological arena.
Researchers are looking into urine tests that could detect cancers earlier, including lung, ovarian, pancreatic, colorectal, and more.
Understanding pancreatic cancer’s strengths may provide clues to its weaknesses.
Based on estimates from the National Cancer Institute, in 2023, more than 110,000 cases of gynecologic cancers are expected...
Although not as common as breast, prostate, or lung cancer, kidney cancer is one of the most frequently diagnosed...
Sometimes referred to as stage 0 breast cancer, ductal carcinoma in situ (DCIS) is a noninvasive growth of abnormal...